Brilliant IP in a Toxic Infrastructure Kills Valuations—and Stalls Regulatory Clearance.
We execute zero-agent 48-Hour M&A Cyber Sprints, Day-1 TSA Carve-Outs, and FDA §524B / PCI DSS 4.0 / SEC Architecture Remediation. By replacing IT checklists with verifiable cloud, AI, and OT evidence, we equip Private Equity Deal Teams, Portfolio CISOs, and MedTech/FinTech Leaders to price CapEx holdbacks, clear RWI exclusions, exit costly TSAs, and unblock regulatory & enterprise revenue gates.
AUTHORIZED ENTERPRISE PARTNER
All inquiries are strictly confidential. We respond within 12 hours.
48-Hour M&A Cyber Sprints, Day-1 Carve-Outs & Regulatory Surge
The Thesis:
Traditional financial diligence validates historical EBITDA, while standard cyber audits deliver 300-row vulnerability spreadsheets weeks too late—neither quantifies the hard-dollar engineering CapEx required to separate a carve-out, clear an FDA or Sponsor-Bank review, or insure the asset.
-
The Problem: High-margin IP—whether a healthcare diagnostics roll-up, an AI-enabled Class II/III medical device, or an embedded FinTech ledger—becomes severely devalued or commercially stalled when operating inside entangled parent Active Directory tenants, flat lab/manufacturing OT networks, unvetted LLM pipelines, or unpatched CISA KEVs.
-
The Gap: We bridge Principal systems engineering, multi-cloud & HSM cryptography, and strict statutory gates (FDA §524B / eSTAR, HIPAA, PCI DSS v4.0.1, SEC Reg S-P, FFIEC, IEC 62443 OT) to protect enterprise multiples and unblock commercialization.
The Solution:
We execute zero-agent diagnostics and Principal surge architecture across the full deal and regulatory lifecycle:
-
Buy-Side & Sell-Side Valuation Defense: Convert abstract technical debt into defensible 100-day CapEx escrow holdbacks, QoE OpEx adjustments, and <12-hour pre-wire RWI clearance fixes—or baseline sell-side architecture early to defend exit multiples against 11th-hour buyer re-trades.
-
Day-1 TSA Carve-Outs & Regulatory Unblocking: Deliver execution-ready roadmaps and hands-on Principal engineering for Operating Partners, seated Portfolio CISOs, and QA/RA teams—exiting costly parent TSAs, isolating clinical/industrial OT subnets, closing CDRH AINN holds, and shrinking PCI CDE scope.
Investment & Delivery SLA:
Direct engagements for Lower-Middle to Middle-Market Sponsors ($15M – $250M+ EV) & Regulated Platforms • Turnkey C2C & White-Label Integration (via E-Comm Systems Inc., est. 1999) for MedTech QA/RA & M&A Channel Partners.
Tier 1: The 48-Hour Cloud, AI & OT Diligence Sprint (Flat Fee Starting at $25,000)
-
Hour 0–2: 15-minute read-only AWS/Azure/GCP IAM role setup (0 agents, 0% live load) + Clean-Room VDR ingestion.
-
Hour 24: Executive Red-Flag & RWI Exclusion Briefing.
-
Hour 48: Delivery of the IC CapEx Holdback Memo, QoE OpEx Model, and <12-Hour RWI Clearance Protocol.
Tier 2: 5-to-10 Day Full-Stack, FDA §524B or FinTech Regulatory Surge (Fixed-Fee Scoped)
-
Days 1–3: Agentless cloud/IAM graph, secure-code & leaf-node CycloneDX SBOM/VEX analytics, AI-SPM/PCCP review, or staging pen testing (GXPN/GMOB/GWAPT).
-
Mid-Sprint: Principal Go/No-Go or Deficiency Triage Readout.
-
Final Readout: Complete IC Buyout Dossier, FDA §524B / eSTAR Remediation Package, or PCI DSS v4.0.1 / SEC Reg S-P / HSM Audit Blueprint + 100-Day Execution Plan.
Tier 3: 100-Day Carve-Out Execution, Portfolio CISO & C2C Surge Bench (Retainer or C2C SOW)
-
Post-Close & PortCo Governance: Hands-on Active Directory/cloud TSA exits, IEC 62443 lab/plant OT segmentation, <14-day bolt-on onboarding, and Tier-1 hospital/bank audit defense across 5 to 30+ portfolio companies.
-
Channel Subcontracting: Elastic Principal surge engineering under mutual NDA for MedTech QA/RA consultancies, CDMOs, and QoE/M&A advisory practices.
Our Methodology: The IP-Safe Guarantee. Zero-Friction. Zero-Agent.
Built to Respect Engineering Bandwidth.
Engineering teams are understandably protective of live infrastructure during M&A exclusivity, TSA carve-outs, and high-stakes regulatory filings. Standard audits stall product velocity with 300-row spreadsheets, kernel agents, and reckless network sweeps. We execute a strictly out-of-band, Principal-led, read-only protocol:
-
15-Minute Out-of-Band Cloud, AI & IAM Telemetry (Wiz Enterprise Partner): Target DevOps deploys a human-readable, read-only IAM role across AWS, Azure, or GCP in 15 minutes (revocable in 30 seconds). Leveraging Wiz’s agentless graph, we map IAM blast radiuses, shadow AI pipelines, KMS/HSM key custody, and toxic attack paths with zero agents installed and 0.0% production load.
-
Passive Lab, Manufacturing & Clinical OT Inspection (IEC 62443): We evaluate exported firewall ACLs, VLAN routing tables, and architecture topologies offline—never firing active Nmap/Nessus port scans against fragile Class II/III medical devices, diagnostic lab analyzers, industrial PLCs, or payment HSM enclaves.
-
Zero-Clone SBOM, License & Dependency Analytics: Using read-only metadata and leaf-node CycloneDX SBOM / VEX ingestion, we pinpoint unpatched CISA KEVs, hardcoded secrets, EOL runtimes, and restrictive AGPLv3 copyleft IP contamination—without ever cloning source repositories or touching proprietary algorithms or ePHI/PAN payloads.
-
Ephemeral AWS Clean-Room & Cryptographic Destruction Custody: Submitted VDR and regulatory artifacts never touch consultant laptops. Every engagement runs inside a single-tenant AWS Clean-Room VPC encrypted under a deal-specific AWS KMS Customer-Managed Key (CMK)—irreversibly destroyed within 24 hours of sign-off with a SHA-256 Signed Certificate of Destruction issued to Sponsor and Seller counsel.
Our Approach to Partnership
We do not run check-the-box IT questionnaires—we engineer verifiable security architecture that protects enterprise multiples, clears statutory gates, and accelerates exits. We engage directly with Private Equity Deal Teams, Operating Partners, Seated Portfolio CISOs, and MedTech/FinTech Executives, while also operating as a confidential Corp-to-Corp (C2C) and white-label Principal bench (via E-Comm Systems Inc., est. 1999) for MedTech QA/RA consultancies, CDMOs, Quality-of-Earnings practices, and M&A advisory firms.
Whether quantifying CapEx escrow holdbacks and RWI exclusions in 48 hours, separating entangled parent AD/cloud TSAs and flat lab/plant OT networks (IEC 62443), closing FDA Section 524B / eSTAR AINN holds, or unblocking PCI DSS v4.0.1, SEC Reg S-P, and Sponsor-Bank FFIEC reviews, we plug in seamlessly as a senior extension of your deal, engineering, or delivery team—with zero junior handoffs and strict non-poaching channel integrity.
Executive Leadership & Advisory
Operating as the specialized executive cybersecurity and M&A advisory division of E-Comm Systems Inc. (established 1999) in Saint Paul, Minnesota, QuantSec Advisory brings 20+ years of battle-tested Principal security architecture to Private Equity sponsors, portfolio companies, regulated MedTech/FinTech platforms, and C2C advisory partners.
Practice Lead Ruben Benegas, MS, CISSP has directed product, cloud, and cryptographic security across some of the world’s most scrutinized regulated environments—serving as Lead Product Cybersecurity Architect (Contract) at Medtronic (Class II/III connected devices, FDA §524B, $5M/yr mobile security transformation), Principal Security Engineer at U.S. Bank (AI/ML vulnerability triage & OCC/FFIEC cloud defense), and Vice President & Lead Security Engineer at Wells Fargo (FIPS 140-3 HSM cryptography, PKI, and multi-cloud governance), alongside architecture mandates for Boston Scientific, Alcon Research, QBE Insurance, and Thomson Reuters.
Backed by an M.S. in Software Engineering (Computer Security), an M.A. in International Management (Finance), CISSP, CCSP, CCSK, AWS, and 9 GIAC offensive & cloud certifications (GXPN, GPEN, GWAPT, GMOB, GAWN, GCIH, GPYC), Ruben bridges deep packet-, firmware-, and cloud-level reality with Investment Committee and regulatory fluency.
— Ruben Benegas, MS, CISSP, Principal Security Architect & Fractional CISO
Connect with Ruben on LinkedIn
PROVEN ENTERPRISE IMPACT
Hard-Dollar Outcomes & Execution.
$5M/Yr Mobile Security Transformation: Spearheaded the global architectural migration to automated MASVS mobile security validation across regulated Class II/III companion apps—capturing $5M in annual OpEx savings for a Fortune 500 medical device leader.
AI-SecOps Triage (-75% Engineering Drag): Deployed machine-learning and locally hosted LLM code-analysis workflows across Tier-1 banking CI/CD pipelines—slashing AppSec/container false-positive triage time by 75% and accelerating audit-ready GRC evidence.
M&A Cloud, IAM & OT Risk Isolation (-40% Attack Surface): Reduced external multi-cloud attack surfaces by 40%, eliminated cross-account IAM blast radiuses, and architected clean AD/cloud TSA separations and IEC 62443 OT boundaries for enterprise and PE-backed platforms.
FDA §524B & Connected Device Clearance: Directed end-to-end product cybersecurity across Class II/III BLE, mobile, and cloud device ecosystems—delivering traceable DFD-to-STRIDE threat models (AAMI SW96), leaf-node CycloneDX SBOM/VEX, and hardware-backed Secure Boot/OTA PKI.
FIPS 140-3 HSM Custody & Tier-1 Banking Defense: Architected enterprise HSM cryptographic enclaves, KMS key-lifecycle governance, and PCI DSS v4.0.1 / FFIEC / GLBA / SEC Reg S-P controls across high-availability settlement, mortgage, and wealth platforms.
Zero-Day & Software Supply-Chain Containment: Built automated SBOM/KEV telemetry pipelines and rapid containment playbooks across critical financial and retail infrastructure—neutralizing zero-day disclosures with zero unplanned production downtime.
LATEST POSTS
Initiate a Scoping Call or Sprint
Partner with QuantSec Advisory to price M&A cyber risk in 48 hours, execute a Day-1 TSA/OT carve-out, unblock FDA §524B or PCI DSS 4.0 clearance, or deploy C2C Principal surge capacity under your firm’s SOW. All inquiries are strictly confidential under mutual NDA, with Principal responses guaranteed within 12 hours.